PureTech Health plc (LON:PRTC)
121.60
-4.40 (-3.49%)
Sep 4, 2026, 4:35 PM GMT
PureTech Health Market Cap
PureTech Health has a market cap or net worth of 296 million as of September 4, 2026. Its market cap has increased by 5.22% in one year.
Market Cap
296.00M
Enterprise Value
227.75M
Revenue
3.46M
Ranking
n/a
PE Ratio
n/a
Stock Price
121.60
ChartMarket Cap Chart
Since June 19, 2015, PureTech Health's market cap has decreased from 404.50M to 296.00M, a decrease of -26.82%. That is a compound annual growth rate of -2.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 296.00M | -2.02% |
| Dec 31, 2025 | 302.11M | -15.99% |
| Dec 31, 2024 | 359.61M | -31.88% |
| Dec 29, 2023 | 527.94M | -28.89% |
| Dec 30, 2022 | 742.38M | -11.66% |
| Dec 31, 2021 | 840.37M | -26.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Oxford Nanopore Technologies | 1.69B |
| Genus | 1.53B |
| Oxford Biomedica | 513.20M |
| Avacta Group | 313.83M |
| Scancell Holdings | 115.77M |
| Bioventix | 90.39M |
| Faron Pharmaceuticals Oy | 77.09M |
| 4basebio | 73.81M |